A groundbreaking analysis of over 3.4 million cancer patients reveals a striking shift in postoperative mortality. For 14 of 21 solid tumors, non-cancer deaths—including cardiovascular diseases and infections—now dominate, accounting for nearly half of post-surgical fatalities. Surgical interventions amplifying these risks require urgent attention, especially for lung and pancreatic cancer patients. While short-term mortality has improved, deeper disparities persist, highlighting an acute need for comprehensive post-operative care focused on managing non-cancer comorbidities.
Journal Article by Hao Y, Liang C (…) Zhao B et 8 al. in Int J Surg
Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.
